Tag: QuieremScout
Combining targeted Holmium-166 radioembolization with systemic therapy improves response rates in...
This article is sponsored by Terumo.
The first prospective study on the combination of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and Holmium-166 (166Ho) radioembolization...
